Stimulation of DNA synthesis but not of peroxisomal beta-oxidation by nafenopin in primary cultures of marmoset hepatocytes. 1988

F Bieri, and W Stäubli, and F Waechter, and S Muakkassah-Kelly, and P Bentley
Central Toxicology Unit, Ciba-Geigy Limited, Basel, Switzerland.

The effects of the peroxisome proliferator nafenopin upon primary cultures of marmoset hepatocytes have been investigated and compared to those on cultured rat hepatocytes. Nafenopin did not induce peroxisomal beta-oxidation or peroxisome proliferation but did induce replicative DNA synthesis. These findings demonstrate that peroxisome proliferation and mitogenicity are two independent properties of nafenopin and question the widely held view that primates are generally insensitive to the effects of peroxisome proliferators.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D008830 Microbodies Electron-dense cytoplasmic particles bounded by a single membrane, such as PEROXISOMES; GLYOXYSOMES; and glycosomes. Glycosomes,Glycosome,Microbody
D009255 Nafenopin A peroxisome proliferator that is used experimentally to promote liver tumors. It has been used as an antihyperlipoproteinemic agent. CH-13437,Melipan,Nafenoic Acid,SU-13,437,Acid, Nafenoic,CH 13437,CH13437,SU 13,437,SU13,437
D010084 Oxidation-Reduction A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs (Lehninger, Principles of Biochemistry, 1982, p471). Redox,Oxidation Reduction
D011422 Propionates Derivatives of propionic acid. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain the carboxyethane structure. Propanoate,Propanoic Acid,Propionate,Propanoates,Propanoic Acid Derivatives,Propanoic Acids,Propionic Acid Derivatives,Propionic Acids,Acid, Propanoic,Acids, Propanoic,Acids, Propionic,Derivatives, Propanoic Acid,Derivatives, Propionic Acid
D002143 Callitrichinae A subfamily in the family CEBIDAE that consists of four genera: CALLITHRIX (marmosets), CALLIMICO (Goeldi's monkey), LEONTOPITHECUS (lion tamarins), and SAGUINUS (long-tusked tamarins). The members of this family inhabit the tropical forests of South and Central America. Cebuella,Genus Mico,Leontocebus,Mico Genus,Callithricidae,Callitrichidae,Cebuellas,Genus, Mico,Mico, Genus
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

F Bieri, and W Stäubli, and F Waechter, and S Muakkassah-Kelly, and P Bentley
October 1992, Biochimica et biophysica acta,
F Bieri, and W Stäubli, and F Waechter, and S Muakkassah-Kelly, and P Bentley
August 1987, Biochemical and biophysical research communications,
F Bieri, and W Stäubli, and F Waechter, and S Muakkassah-Kelly, and P Bentley
October 1976, Proceedings of the National Academy of Sciences of the United States of America,
F Bieri, and W Stäubli, and F Waechter, and S Muakkassah-Kelly, and P Bentley
May 1985, Journal of biochemistry,
F Bieri, and W Stäubli, and F Waechter, and S Muakkassah-Kelly, and P Bentley
September 2000, European journal of pharmacology,
F Bieri, and W Stäubli, and F Waechter, and S Muakkassah-Kelly, and P Bentley
October 1993, Ecotoxicology and environmental safety,
F Bieri, and W Stäubli, and F Waechter, and S Muakkassah-Kelly, and P Bentley
February 1982, In vitro,
F Bieri, and W Stäubli, and F Waechter, and S Muakkassah-Kelly, and P Bentley
April 1988, Carcinogenesis,
F Bieri, and W Stäubli, and F Waechter, and S Muakkassah-Kelly, and P Bentley
January 1992, The Biochemical journal,
F Bieri, and W Stäubli, and F Waechter, and S Muakkassah-Kelly, and P Bentley
October 1999, The Journal of pharmacology and experimental therapeutics,
Copied contents to your clipboard!